Other Species / Isoforms
  POLD3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y42-p
NQAKQMLyDyVERKR
0 1
POLD3 (human) NQAKQMLyDyVERKR Y42-p
POLD3 (mouse) NQAKQMLYEYVERKR Y42
POLD3 (rat) NQAKQMLYEYVERKR Y42
Y44-p
AKQMLyDyVERKRKE
0 1
POLD3 (human) AKQMLyDyVERKRKE Y44-p
POLD3 (mouse) AKQMLYEYVERKRKE Y44
POLD3 (rat) AKQMLYEYVERKRKE Y44
S90-p
DKLEAVKsKLAVtAS
0 1
POLD3 (human) DKLEAVKsKLAVtAS S90-p
POLD3 (mouse) DKLEAVKSKLAVTAS S90
POLD3 (rat) DRLEAVKSKLAVTAS S90
T95-p
VKsKLAVtASIHVyS
0 1
POLD3 (human) VKsKLAVtASIHVyS T95-p
POLD3 (mouse) VKSKLAVTASIHVYS T95
POLD3 (rat) VKSKLAVTASIHVYS T95
Y101-p
VtASIHVySIQKAML
0 1
POLD3 (human) VtASIHVySIQKAML Y101-p
POLD3 (mouse) VTASIHVYSIQKAML Y101
POLD3 (rat) VTASIHVYSIQKAML Y101
K109-ub
SIQKAMLkDSGPLFN
0 1
POLD3 (human) SIQKAMLkDSGPLFN K109-ub
POLD3 (mouse) SIQKAMLKDSGPLFN K109
POLD3 (rat) SIQKAMLKDSGPLFN K109
K123-ub
NTDYDILkSNLQNCS
0 1
POLD3 (human) NTDYDILkSNLQNCS K123-ub
POLD3 (mouse) NTDYDILKSNLQNCS K123
POLD3 (rat) NTDYDILKSNLQNCS K123
K131-ub
SNLQNCSkFsAIQCA
0 3
POLD3 (human) SNLQNCSkFsAIQCA K131-ub
POLD3 (mouse) SNLQNCSKFSAIQCA K131
POLD3 (rat) SNLQNCSKFSAIQCA K131
K131-sm
SNLQNCSkFsAIQCA
0 1
POLD3 (human) SNLQNCSkFsAIQCA K131-sm
POLD3 (mouse) SNLQNCSKFSAIQCA K131
POLD3 (rat) SNLQNCSKFSAIQCA K131
S133-p
LQNCSkFsAIQCAAA
0 1
POLD3 (human) LQNCSkFsAIQCAAA S133-p
POLD3 (mouse) LQNCSKFSAIQCAAA S133
POLD3 (rat) LQNCSKFSAIQCAAA S133
S148
VPRAPAESSSSSKKF
0 2
POLD3 (human) VPRAPAESSSSSKKF S148
POLD3 (mouse) VPRAPAEsPSSRKYE S148-p
POLD3 (rat) VPRAPAESSSSRKFE S148
T173-p
TQANNELtTNGHGPP
0 1
POLD3 (human) TQANNELtTNGHGPP T173-p
POLD3 (mouse) EAQASELTTNGHGPP T171
POLD3 (rat) ETQASELTTNGHGPP T171
K203-ac
FASKAAAkTQEtNKE
0 1
POLD3 (human) FASKAAAkTQEtNKE K203-ac
POLD3 (mouse) LISKAATKTQDTNKE K201
POLD3 (rat) LISKAATKTQDTNKD K201
T207-p
AAAkTQEtNKETKTE
0 1
POLD3 (human) AAAkTQEtNKETKTE T207-p
POLD3 (mouse) AATKTQDTNKETKPE T205
POLD3 (rat) AATKTQDTNKDTKTE T205
K216-sm
KETKTEAkEVTNAsA
0 1
POLD3 (human) KETKTEAkEVTNAsA K216-sm
POLD3 (mouse) KETKPEAREVTSASS R214
POLD3 (rat) KDTKTEAREVTSASS R214
S222-p
AkEVTNAsAAGNKAP
0 1
POLD3 (human) AkEVTNAsAAGNKAP S222-p
POLD3 (mouse) AREVTSASSAGGKAP S220
POLD3 (rat) AREVTSASSAGGKAP S220
K231-sm
AGNKAPGkGNMMSNF
0 1
POLD3 (human) AGNKAPGkGNMMSNF K231-sm
POLD3 (mouse) AGGKAPGKGSVMSNF K229
POLD3 (rat) AGGKAPGKGNVMSNF K229
K246-ac
FGKAAMNkFkVNLDs
0 1
POLD3 (human) FGKAAMNkFkVNLDs K246-ac
POLD3 (mouse) FGKAAMNKLKVNLDS K244
POLD3 (rat) FGKAAMSKLKVNLDS K244
K248-m1
KAAMNkFkVNLDsEQ
0 1
POLD3 (human) KAAMNkFkVNLDsEQ K248-m1
POLD3 (mouse) KAAMNKLKVNLDSEQ K246
POLD3 (rat) KAAMSKLKVNLDSEQ K246
S253-p
kFkVNLDsEQAVkEE
0 1
POLD3 (human) kFkVNLDsEQAVkEE S253-p
POLD3 (mouse) KLKVNLDSEQAVKEE S251
POLD3 (rat) KLKVNLDSEQAVKEE S251
K258-sm
LDsEQAVkEEKIVEQ
1 2
POLD3 (human) LDsEQAVkEEKIVEQ K258-sm
POLD3 (mouse) LDSEQAVKEEKTVEQ K256
POLD3 (rat) LDSEQAVKEEKTVEQ K256
K274-sm
TVSVTEPkLAtPAGL
0 1
POLD3 (human) TVSVTEPkLAtPAGL K274-sm
POLD3 (mouse) PVSVTEPKLAAPPAQ K272
POLD3 (rat) PVSVAEPKLAAPPAL K272
T277-p
VTEPkLAtPAGLkKs
Upstream
0 11
Treatment
  • ischemia
  • MG132_withdrawal
POLD3 (human) VTEPkLAtPAGLkKs T277-p
POLD3 (mouse) VTEPKLAAPPAQKKS A275
POLD3 (rat) VAEPKLAAPPALKKS A275
K282-ac
LAtPAGLkKsSkkAE
0 1
POLD3 (human) LAtPAGLkKsSkkAE K282-ac
POLD3 (mouse) LAAPPAQKKSSRKSE K280
POLD3 (rat) LAAPPALKKSSRKSE K280
S284-p
tPAGLkKsSkkAEPV
0 1
POLD3 (human) tPAGLkKsSkkAEPV S284-p
POLD3 (mouse) APPAQKKSSRKSEPG S282
POLD3 (rat) APPALKKSSRKSEPV S282
K286-ac
AGLkKsSkkAEPVKV
0 1
POLD3 (human) AGLkKsSkkAEPVKV K286-ac
POLD3 (mouse) PAQKKSSRKSEPGKV R284
POLD3 (rat) PALKKSSRKSEPVKM R284
K287-ac
GLkKsSkkAEPVKVL
0 1
POLD3 (human) GLkKsSkkAEPVKVL K287-ac
POLD3 (mouse) AQKKSSRKSEPGKVQ K285
POLD3 (rat) ALKKSSRKSEPVKMQ K285
K298-ac
VKVLQKEkKRGkRVA
0 1
POLD3 (human) VKVLQKEkKRGkRVA K298-ac
POLD3 (mouse) GKVQQKEKSSRGKRV K296
POLD3 (rat) VKMQQKEKKCRGKRV K296
K302-ac
QKEkKRGkRVALsDD
0 1
POLD3 (human) QKEkKRGkRVALsDD K302-ac
POLD3 (mouse) KEKSSRGKRVDLsDE K301
POLD3 (rat) KEKKCRGKRVDLsDE K301
S307-p
RGkRVALsDDEtKEt
Upstream
0 77
Treatment
  • EGF
  • MG132_withdrawal
POLD3 (human) RGkRVALsDDEtKEt S307-p
POLD3 (mouse) RGKRVDLsDEEAKET S306-p
POLD3 (rat) RGKRVDLsDEEAKET S306-p
T311-p
VALsDDEtKEtENMR
0 2
POLD3 (human) VALsDDEtKEtENMR T311-p
POLD3 (mouse) VDLsDEEAKETEHLK A310
POLD3 (rat) VDLsDEEAKETENLK A310
T314-p
sDDEtKEtENMRKKR
0 1
POLD3 (human) sDDEtKEtENMRKKR T314-p
POLD3 (mouse) sDEEAKETEHLKKKR T313
POLD3 (rat) sDEEAKETENLKKKR T313
S371-p
KTEPEPPsVKssSGE
0 1
POLD3 (human) KTEPEPPsVKssSGE S371-p
POLD3 (mouse) gap -
POLD3 (rat) gap -
S374-p
PEPPsVKssSGENKR
0 1
POLD3 (human) PEPPsVKssSGENKR S374-p
POLD3 (mouse) TEPPPVKRSSGETKR R370
POLD3 (rat) TEPPPVKRSSGENKR R370
S375-p
EPPsVKssSGENKRK
0 1
POLD3 (human) EPPsVKssSGENKRK S375-p
POLD3 (mouse) EPPPVKRSSGETKRR S371
POLD3 (rat) EPPPVKRSSGENKRK S371
S407-p
VTEKVYEsEsCtDsE
0 3
POLD3 (human) VTEKVYEsEsCtDsE S407-p
POLD3 (mouse) VTEKVYEsEsCtDsE S403-p
POLD3 (rat) VTEKVYESESCTDSE S403
S409-p
EKVYEsEsCtDsEEE
0 3
POLD3 (human) EKVYEsEsCtDsEEE S409-p
POLD3 (mouse) EKVYEsEsCtDsEEE S405-p
POLD3 (rat) EKVYESESCTDSEEE S405
T411-p
VYEsEsCtDsEEELN
0 4
POLD3 (human) VYEsEsCtDsEEELN T411-p
POLD3 (mouse) VYEsEsCtDsEEELK T407-p
POLD3 (rat) VYESESCTDSEEETK T407
S413-p
EsEsCtDsEEELNMK
0 5
POLD3 (human) EsEsCtDsEEELNMK S413-p
POLD3 (mouse) EsEsCtDsEEELKMK S409-p
POLD3 (rat) ESESCTDSEEETKMK S409
S423-p
ELNMKTSsVHRPPAM
0 2
POLD3 (human) ELNMKTSsVHRPPAM S423-p
POLD3 (mouse) ELKMKPASAHKPPAA S419
POLD3 (rat) ETKMKMASAQRPPAA S419
K433-sm
RPPAMTVkKEPREER
1 2
POLD3 (human) RPPAMTVkKEPREER K433-sm
POLD3 (mouse) KPPAAAVKREPREER K429
POLD3 (rat) RPPAATVKREPREER K429
K444-ac
REERKGPkKGTAALG
0 1
POLD3 (human) REERKGPkKGTAALG K444-ac
POLD3 (mouse) REERKGPKKGAAALG K440
POLD3 (rat) REERKGPKKGAAALG K440
K452-ac
KGTAALGkANRQVsI
0 3
POLD3 (human) KGTAALGkANRQVsI K452-ac
POLD3 (mouse) KGAAALGKANRQVsI K448
POLD3 (rat) KGAAALGkANRQVsI K448-ac
S458-p
GkANRQVsITGFFQR
Upstream
Downstream
1 47
Effects on Modified Protein
  • enzymatic activity, altered
  • molecular association, regulation
Kinase, in vitro:
  • PKACA (human)
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • ischemia
POLD3 (human) GkANRQVsITGFFQR S458-p
POLD3 (mouse) GKANRQVsITGFFQK S454-p
POLD3 (rat) GkANRQVsITGFFQK S454-p